Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias.
about
Epilepsy related to developmental tumors and malformations of cortical developmentDiagnostic methods and treatment options for focal cortical dysplasiaA pulse rapamycin therapy for infantile spasms and associated cognitive decline.The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response.Evidence for Resident Memory T Cells in Rasmussen Encephalitis.Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis.Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy.The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant Epilepsy.Cytokines and brain excitability.Imaging Brain Inflammation: If We Can See It, Maybe We Can Treat It.Differential expression of major histocompatibility complex class I in developmental glioneuronal lesionsBrain inflammation as a biomarker in epilepsy.Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune responseDevelopmental patterns of DR6 in normal human hippocampus and in Down syndromeDoes brain inflammation mediate pathological outcomes in epilepsy?Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus.Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator ProteinThe role of inflammation in epilepsyInflammation in epilepsy: clinical observations.Epileptic encephalitis: the role of the innate and adaptive immune system.Inflammatory pathways of seizure disorders.Inflammation and epilepsy in the developing brain: clinical and experimental evidence.Immunity and Inflammation in Epilepsy.Recent advances in epilepsy.Sterile Neuroinflammation and Strategies for Therapeutic InterventionInnate and adaptive immunity in human epilepsies.Cytochrome c oxidase deficit is associated with the seizure onset zone in young patients with focal cortical dysplasia Type II.Transient and chronic seizure-induced inflammation in human focal epilepsy.The interleukin 17 system in cortical lesions in focal cortical dysplasias.Cell injury and premature neurodegeneration in focal malformations of cortical development.Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.Correlation between clinical and histologic findings in the human neonatal hippocampus after perinatal asphyxia.Comparative analysis of cytokine/chemokine regulatory networks in patients with hippocampal sclerosis (HS) and focal cortical dysplasia (FCD).Clinical studies and anti-inflammatory mechanisms of treatments.α-Asarone Attenuates Cognitive Deficit in a Pilocarpine-Induced Status Epilepticus Rat Model via a Decrease in the Nuclear Factor-κB Activation and Reduction in Microglia Neuroinflammation.
P2860
Q26829946-1E8A0248-C7B6-4ECD-AA13-17DC07AE151FQ28081144-BE427FAF-1AFE-442A-B714-6DBE4028543DQ30501073-1D78687D-A156-46FB-A05C-2B33A5892A51Q30576758-16F7CCF3-7752-40BD-AC6B-D62E4AB260A9Q30741122-5D4645B3-9296-4F4F-A572-8597A3D8ACBDQ30804418-DC120045-48A1-46BF-A8E3-1600480BAD11Q34427432-C43DDEE9-24B8-460A-A56A-1BF3BAD8A241Q34516912-A430C5E0-263B-473E-B92E-623DAA2CC0F8Q35863667-D0D86CE2-4391-443A-A910-D7BBD86B48A1Q36490729-992FF3DC-FF11-4C9B-8E08-EC197C64781CQ36505024-7965D815-F1B9-4941-9B47-E9DF012364E0Q36542185-FE57593C-A636-4A47-8879-48C58F95A4A1Q36567422-9C7AD073-A38D-4FDE-B60A-72B470AB78F4Q36591782-C13D1410-993C-4D80-9413-71089F9D0F6BQ36763895-E4C43FE4-C408-487F-AC41-D54F9056B5B5Q36815367-452E5907-E8AF-4D69-8485-FED4DD34884AQ36854093-AA9351FB-7CCF-4640-95C3-F8E3840E0391Q36884903-A9F66DC0-46E9-457F-93C3-7B79FC8D6DA2Q36901520-1E8D0FBD-8356-42AD-966A-D8765CDB7D46Q37430765-3D0A3065-FB7B-40DE-B059-51F50038AB8AQ37584734-77BB112C-36C1-4A7D-A3E3-133918288357Q37816957-588054BE-FD7E-42A7-AD08-73A359BA7223Q37872029-4DF9905F-928E-4668-A468-0F2EC787E647Q38002125-E4DB2035-8498-45CF-B174-3A6477C0B5B1Q38172740-71FFCFED-7901-48E1-834D-5DE5C6015852Q38325826-568498A3-3839-46E6-8C50-727CD3D9298DQ38673807-12EE3D34-26CD-460C-9D69-F84486083195Q39000942-C8B6F310-52DF-46F6-960E-C0CEC8EA93BCQ39105980-337DA906-077B-4016-9744-6756A921118BQ40135696-774C12E9-D42A-431D-AA97-70391EB1F9ADQ41751004-4149AB3B-CAF3-4B4A-8C24-2DC75C4282D5Q42327985-E6673828-354A-43B8-9DBD-EB7B0ABEFF08Q44270195-003EA15E-23C4-4334-A238-E0C83F1A30D1Q45213406-F3107B31-22A9-4BF4-82EB-4C5345E15A89Q45821604-92BC8AAE-01C9-4684-A22E-38825160DFB0Q45865000-B98EEB03-4578-4E07-973A-9367EE8D2EEFQ46482414-7DEB2A14-93EC-484D-9412-861A482103C2Q46965486-954D11F3-41AD-406E-B088-7BF768552017Q47124754-4A046259-A175-4A86-82E6-4B8C6CDE5BE2Q47194378-932F6F25-5C4B-4597-8B26-9587C889A767
P2860
Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Evaluation of the innate and a ...... II focal cortical dysplasias.
@en
Evaluation of the innate and a ...... II focal cortical dysplasias.
@nl
type
label
Evaluation of the innate and a ...... II focal cortical dysplasias.
@en
Evaluation of the innate and a ...... II focal cortical dysplasias.
@nl
prefLabel
Evaluation of the innate and a ...... II focal cortical dysplasias.
@en
Evaluation of the innate and a ...... II focal cortical dysplasias.
@nl
P2093
P1433
P1476
Evaluation of the innate and a ...... II focal cortical dysplasias.
@en
P2093
Anand Iyer
Emanuele Zurolo
Jan A Gorter
Johannes C Baayen
Peter C van Rijen
Wim G M Spliet
P304
P356
10.1111/J.1528-1167.2010.02547.X
P577
2010-09-01T00:00:00Z